Urology Devices Market - Global Forecast 2025-2032

The urology devices market is undergoing rapid change as decision-makers face increasing complexity and a heightened need for actionable strategic guidance. Leaders are challenged to identify credible insights that inform sustainable growth, competitiveness, and compliance in a shifting global healthcare landscape.

Market Snapshot: Urology Devices Market Size and Growth Outlook

The urology devices market is extending its growth trajectory, expanding from USD 44.41 billion in 2024 to USD 48.56 billion in 2025, with forecasts placing market value at USD 91.88 billion by 2032. This translates to a compound annual growth rate of 9.51%. Sector momentum is driven by rising demand for minimally invasive procedures and accelerated integration of digital diagnostics. Evolving clinical care prioritizes patient-centered models and favors value-based procurement. Meanwhile, shifting demographic profiles broaden the addressable patient pool, further intensifying the need for ongoing innovation. Regulatory changes and supply chain pressures emphasize agility and adaptability for organizations seeking to keep pace in this dynamic environment.

Scope & Segmentation of the Urology Devices Market

This comprehensive report equips senior executives with structured intelligence designed for strategic clarity across key segments, including technologies, products, and regional players:

• Product Type: Devices cover continence management, penile prosthesis, and a broad range of endoscopic instruments—such as cystoscopes, nephroscopes, and ureteroscopes. Solutions also include tools for stone management, various ureteral stents, and fully integrated urodynamic systems.
• Technology: Assesses disposable and reusable platforms, with a focus on their impact on clinical workflow, operational efficiency, and procurement decisions across healthcare settings.
• Application: Encompasses device use in treating benign prostatic conditions, cancer, urinary incontinence, kidney stone management, and urinary tract infections.
• End User: Examines procurement and clinical practice patterns in hospitals, ambulatory surgical centers, and dedicated clinics, highlighting segment-specific adoption factors.
• Geography: Provides in-depth analysis across the Americas, Europe, Asia-Pacific, Middle East, and Africa, addressing unique local regulatory, healthcare delivery, and supply chain considerations.
• Major Companies: Includes strategic profiles for Boston Scientific Corporation, Johnson & Johnson, Olympus Corporation, Medtronic plc, Stryker Corporation, Teleflex Incorporated, Coloplast A/S, Cook Medical LLC, KARL STORZ SE & Co. KG, and Richard Wolf GmbH.

Key Takeaways for Senior Decision-Makers

• Minimally invasive treatments and chronic urinary conditions are redefining procurement and clinical adoption standards for providers and payers.
• Technological advances such as AI-driven diagnostic platforms and the integration of remote patient monitoring are opening new clinical pathways.
• Manufacturers are adapting compliance strategies in response to rapid regulatory developments around digital and software-enabled technologies.
• Collaboration between device manufacturers, pharmaceutical firms, and academic centers is expediting new technology launches and market uptake.
• Procurement departments increasingly favor value-based frameworks to optimize supply expenditures, device lifecycle, and collaborative care models.

Tariff Impact: Strengthening the Urology Device Supply Chain

Recent U.S. tariffs have caused manufacturers to broaden sourcing networks and build local supply partnerships to better manage cost pressures. This proactive approach is supporting a stronger, more resilient supply chain. Companies are also emphasizing regional manufacturing facilities and regulatory compliance streamlining to remain competitive amid evolving trade landscapes.

Methodology & Data Sources

Findings in this report are grounded in both primary and secondary research approaches. Key sources include regulatory filings, academic and peer-reviewed publications, proprietary clinical outcomes data, and market perspectives. Interviews with clinicians, procurement authorities, and policy experts bolster insight reliability and practical relevance.

Why This Report Matters

• Supplies in-depth, actionable market segmentation and intelligence to assist leaders in refining procurement processes and preparing for future market changes.
• Delivers essential context for developing supply chain and compliance strategies tailored to the evolving global business environment.
• Empowers executive decision-makers to identify growth areas, strengthen risk management practices, and pursue collaborative models that drive competitive value.

Conclusion

Senior leadership teams that focus on technology modernization, strategic procurement, and cross-sector alliances will be positioned to address evolving requirements in the urology devices sector and achieve sustainable business progress.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.